Cingulate Stock Forward View - Double Exponential Smoothing
| CING Stock | USD 8.69 -0.43 -4.71% |
Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.65 | EPS Estimate Current Year -11.82 | EPS Estimate Next Year -1.41 | Wall Street Target Price 27.772 | EPS Estimate Current Quarter -0.75 |
This view connects Cingulate headline attention with price response and peer context.
The Double Exponential Smoothing forecasted value of Cingulate on the next trading day is expected to be 8.87 with a mean absolute deviation of 0.30 and the sum of the absolute errors of 18.04.Cingulate after-hype prediction price | $ 8.77 |
Hype metrics are shown as one component among forecasting, technical, analyst, and earnings context.
Cingulate | Build AI portfolio with Cingulate Stock |
Cingulate Additional Predictive Modules
Most predictive techniques to examine Cingulate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cingulate using various technical indicators. When you analyze Cingulate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Double Exponential Smoothing Price Forecast For the 15th of March 2026
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Cingulate on the next trading day is expected to be 8.87 with a mean absolute deviation of 0.30 , mean absolute percentage error of 0.14 , and the sum of the absolute errors of 18.04 .Please note that although there have been many attempts to predict Cingulate Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cingulate's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Cingulate | Cingulate Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Cingulate uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Cingulate stock data series using in forecasting. Note that when a statistical model is used to represent Cingulate stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0646 |
| MAD | Mean absolute deviation | 0.3006 |
| MAPE | Mean absolute percentage error | 0.0507 |
| SAE | Sum of the absolute errors | 18.0357 |
Mean reversion opportunities in Cingulate's arise when market prices disconnect from fundamental anchors such as earnings, book value, or historical price-to-earnings multiples.
After-Hype Price Density Analysis
Using probability distributions for Cingulate forecasting acknowledges that no model can consistently predict Cingulate's exact future price. The distribution approach quantifies model uncertainty and helps investors avoid overconfidence in any single forecast.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-hype price analysis for Cingulate provides a news-conditional view of potential price outcomes. Cingulate's after-hype downside and upside margins for the prediction period are 2.97 and 14.57, respectively. This analysis complements technical and fundamental research by adding a news-sentiment dimension to Cingulate's price forecasting.
Current Value
The after-hype framework applied to Cingulate assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cingulate is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cingulate backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cingulate, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.38 | 5.80 | 0.08 | 0.01 | 7 Events | 5 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
8.69 | 8.77 | 0.92 |
|
Hype Timeline
Cingulate is currently traded for 8.69. The company has historical hype elasticity of 0.08, and average elasticity to hype of competition of -0.01. Cingulate is estimated to increase in value after the next headline, with the price projected to jump to 8.77 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.92%, whereas the daily expected return is currently at 1.38%. The volatility of related hype on Cingulate is about 82857.14%, with the expected price after the next announcement by competition of 8.68. Net Loss for the year was -15.55 M with loss before overhead, payroll, taxes, and interest of -12.1 M. Given the investment horizon of 90 days the next estimated press release will be in 7 days. Cross-verify projections for Cingulate using Historical Fundamental Analysis of Cingulate. The view provides historical context for the projection set.Related Hype Analysis
The peer hype comparison table for Cingulate includes downside risk metrics such as value-at-risk and maximum drawdown for Cingulate's competitors. providing context for assessing the relative risk profile of a Cingulate investment.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALLR | Allarity Therapeutics | -0.02 | 8 per month | 4.10 | 0.06 | 8.43 | -7.02 | 29.05 | |
| LEXX | Lexaria Bioscience Corp | 0.02 | 9 per month | 0.00 | -0.04 | 10.61 | -12.05 | 42.53 | |
| LIXT | Lixte Biotechnology Holdings | -0.28 | 8 per month | 0.00 | -0.03 | 10.20 | -6.85 | 22.37 | |
| KAPA | Kairos Pharma | -0.03 | 5 per month | 0.00 | -0.08 | 10.26 | -8.24 | 29.57 | |
| SYBX | Synlogic | 0.05 | 7 per month | 0.00 | -0.12 | 5.36 | -8.45 | 56.19 | |
| CASI | CASI Pharmaceuticals | 0.04 | 8 per month | 0.00 | -0.12 | 11.90 | -8.51 | 98.17 | |
| CLSD | Clearside Biomedical | 0.36 | 6 per month | 0.00 | -0.26 | 7.96 | -17.54 | 83.67 | |
| ENTO | Entero Therapeutics | -0.23 | 6 per month | 0.00 | -0.0036 | 16.86 | -17.06 | 39.61 | |
| NCNA | NuCana PLC | 0.05 | 8 per month | 0.00 | -0.25 | 5.50 | -8.14 | 19.93 | |
| BCTX | Briacell Therapeutics Corp | -0.03 | 7 per month | 0.00 | -0.1 | 7.66 | -8.84 | 98.43 |
Other Forecasting Options for Cingulate
The movement of Cingulate price is the central consideration for investors deciding whether to enter or hold a position. Noise in Cingulate Stock price charts can make it difficult to distinguish meaningful trends from random fluctuations.Cingulate Related Equities
The following equities are related to Cingulate within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Cingulate against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Cingulate Market Strength Events
Investors use market strength indicators for Cingulate to evaluate how the stock performs relative to broader market trends. These indicators support more precise timing of Cingulate positions, helping investors maximize return and minimize poorly-timed trades.
| Accumulation Distribution | 55849.46 | |||
| Daily Balance Of Power | -0.44 | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 8.99 | |||
| Day Typical Price | 8.89 | |||
| Price Action Indicator | -0.52 | |||
| Period Momentum Indicator | -0.43 |
Cingulate Risk Indicators
A careful analysis of Cingulate's basic risk indicators helps investors understand the risk environment surrounding cingulate stock. This understanding is an essential input for forecasting Cingulate's future price and for deciding how to manage the associated investment risk.
| Mean Deviation | 4.53 | |||
| Semi Deviation | 3.81 | |||
| Standard Deviation | 5.72 | |||
| Variance | 32.68 | |||
| Downside Variance | 21.23 | |||
| Semi Variance | 14.51 | |||
| Expected Short fall | -5.17 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cingulate
Coverage intensity for Cingulate matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Cingulate Short Properties
Short sentiment tied to Cingulate matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 3.8 M | |
| Cash And Short Term Investments | 12.2 M |
More Resources for Cingulate Stock Analysis
A comprehensive view of Cingulate starts with financial statements and ratio context. Financial ratios provide context for profitability, efficiency, and growth trends. Outlined below are key reports that provide context for Cingulate Stock:Cross-verify projections for Cingulate using Historical Fundamental Analysis of Cingulate. The view provides historical context for the projection set. For a detailed overview of how to trade Cingulate Stock, see our How to Trade Cingulate Stock guide.Analysis related to Cingulate should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Understanding Cingulate includes distinguishing between market value and book value, where book value reflects Cingulate's accounting equity. Cingulate's market capitalization is 99.76 M. With a P/B ratio of 28.72, the market values Cingulate well above its book equity. Enterprise value stands at 98.22 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Cingulate differs from its quoted price, since each reflects a different lens. For Cingulate, key inputs include a P/B ratio of 28.72, and ROE of -2.76%. Trading price represents the transaction level agreed by market participants.